AUTHORS
Megan Randi Marshall, MD, Griffin S Collins, MD, MAS2, Camila Delgado-González3, Lindsey Corder, MS, PhD4, Shyranda Jones, LCSW5, Yogindra Persaud, MD6, Erica E Kaye, MD, MPH7
AFFILIATIONS
1 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
2 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
3 Universidad Central del Caribe, Bayamón, Puerto Rico, United States
4 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
5 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
6 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
7 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
ABSTRACT
Introduction: People with sickle cell disease (SCD) endure a high burden of suffering throughout their lives. Recurrent episodes of ischemic injury and systemic inflammation result in widespread end-organ damage, multiple medical co-morbidities, and early mortality. In addition to physical suffering, people with SCD endure psychological, social, spiritual, and existential suffering. The impact of SCD is magnified by the impact of systemic racism on quality of life, health, and medical care for people living with the disease. In addition to the total suffering experienced by people with SCD, the advent and widening availability of curative and transformative therapies through stem cell transplantation and gene therapy increasingly complicate treatment decision making for patients and families.
Palliative care (PC) is a holistic, person-centered approach to caring for people with serious health-related suffering, regardless of prognosis, with the aim of improving quality of life for patients and caregivers. Specialty PC teams partner with patients, families, and multidisciplinary clinicians to manage complex symptoms, facilitate communication and decision-making in alignment with goals of care, and support navigation of complex healthcare systems. Given the complex physical, psychological, and social challenges faced by people with SCD, some clinicians advocate for involvement of specialty PC teams in SCD care. Presently, PC integration in SCD remains inconsistent, however, and best practices for PC support in SCD are unknown.
Objective: This study aimed to explore multidisciplinary clinicians’ perspectives on the role of PC in SCD to guide the development of integrated PC models for people with SCD.
Methods: Multidisciplinary SCD clinicians from one pediatric and two adult comprehensive sickle cell centers in Memphis, TN participated in semi-structured focus groups and interviews that elicited clinician perceptions of PC and its role in SCD care. Sessions were audio-recorded, transcribed, and de-identified. A multidisciplinary research team analyzed the transcripts using rapid qualitative analysis to generate key themes and compile and synthesize categorical findings related to potential referral criteria, services that PC teams may provide, and barriers to PC integration.
Results: Thirty-three clinicians participated in a total of five two-part focus groups and four individual interviews. Thirty-one participants completed an optional demographic survey. Reported roles included physicians (n=13, 41.9%), advanced practice providers (n=6, 19.4), case managers/care coordinators (n=4, 12.9%), nurses (n=3, 9.7%), pharmacists (n=2, 6.5%), school coordinator (n=1, 3.2%), and licensed professional counselor (n=1, 3.2%). Clinicians cared for exclusively adult patients (n=7, 22.6%), exclusively pediatric patients (n=15, 48.4%), or a combination (n=9, 29%). Most participants reported no formal instruction or training in PC (n=18, 58.1%).
Four key themes were generated regarding participants' perspectives, attitudes, and beliefs about palliative care in the SCD population: (1) PC is relevant to the needs of people with SCD, (2) Comprehensive SCD care can be enhanced by the involvement of specialty PC teams, (3) Important knowledge gaps need to be addressed for both patients and clinicians about PC, and (4) There is a need for SCD-specific PC models that are responsive to this population's unique needs.
Conclusions: In this qualitative study, multidisciplinary SCD clinicians perceived PC as a relevant and valuable complement to existing multidisciplinary, comprehensive SCD care across the lifespan. Future work will integrate the perspectives of patients and caregivers alongside clinicians to inform the development of innovative, flexible models of specialized PC to serve the unique needs of people affected by SCD across diverse care locations.
Megan Marshall and Griffin Collins contributed equally to the development of this abstract.
DISCLOSURES
Megan Randi Marshall, MD: No relevant conflicts of interest to declare.